# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001601830-24-000043
Filing Date
2024-04-23
Accepted
2024-04-23 17:29:51
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | rxrxannualreport.pdf | ARS | 6505098
| Complete submission text file | 0001601830-24-000043.txt |  | 8958490

Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40323 | Film No.: 24866078
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)